Page last updated: 2024-10-27

flumazenil and Insulin Resistance

flumazenil has been researched along with Insulin Resistance in 1 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ádány, R1
Pikó, P1
Fiatal, S1
Kósa, Z1
Sándor, J1
Bíró, É1
Kósa, K1
Paragh, G1
Bácsné Bába, É1
Veres-Balajti, I1
Bíró, K1
Varga, O1
Balázs, M1

Other Studies

1 other study available for flumazenil and Insulin Resistance

ArticleYear
Prevalence of Insulin Resistance in the Hungarian General and Roma Populations as Defined by Using Data Generated in a Complex Health (Interview and Examination) Survey.
    International journal of environmental research and public health, 2020, 07-04, Volume: 17, Issue:13

    Topics: Adult; Blood Glucose; Cross-Sectional Studies; Europe; Female; Humans; Hungary; Insulin Resistance;

2020